Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
10 /100
LOW RISK
Score updated Oct 27, 2026

GH — Guardant Health, Inc. Dilution Risk Tracker

Track GH dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GH — Get alerts when the score changes →

As of October 27, 2026, Guardant Health, Inc. (GH) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. Guardant Health, Inc. has a market capitalization of $23.45B, 134.20M shares outstanding, 488 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for GH.
🔔 Track GH — Get forecast alerts →

Market Data

Market Cap$23.45B
Shares Outstanding134.20M
Float127.81M
Cash$1.92B
Debt$1.50B
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore10/100DilutionWatch score record
Shares Outstanding134.20MVerified float table or market cache
Public Float127.81MVerified float table or market cache
Market Cap$23.45BMarket data cache
Cash Runway99.0 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 5, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

GH SEC Filing Activity — Last 12 Months

Shares outstanding reported by GH on the cover page of its latest 10-K/10-Q: 134.20M as of July 24, 2026.

DilutionWatch recorded 1 registration or prospectus document for GH (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
S-3shelf registration1Jul 30, 2026
8-Kcurrent report (material event)3Jul 30, 2026
10-Qquarterly report2Jul 30, 2026
DEF 14Aproxy statement1Apr 28, 2026
SC 13G/Aamended passive >5% holder filing1Aug 14, 2026
3initial insider ownership3May 15, 2026
5annual insider ownership124Oct 22, 2026

Institutional Holdings

QoQ: ↑ 13.5% shares (2026Q1 vs prior)
488 institutional holders · 157.79M shares
#1 BlackRock, Inc. 11.55M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 11.25M shares
#3 GOLDMAN SACHS GROUP INC 7.06M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest11.67M
Days to Cover6.7
% of Float9.1%
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-02-19
4 INSIDER TRANSACTION 2026-04-22
4 INSIDER TRANSACTION 2026-04-20
4 INSIDER TRANSACTION 2026-04-16
4 INSIDER TRANSACTION 2026-04-16
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual GH Dilution Snapshot

Guardant Health, Inc. (GH) has a DilutionScore of 10/100, rated Low dilution risk. Score date: October 27, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

GH's DilutionScore has held steady at 10/100 (Low risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 30 – Oct 27, 202610/100LOW89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

GH shares outstanding have increased 1.1% from 131.17M (Mar 2026) to 132.60M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 24, 2026132.60M127.80M▲ 0.19%
May 17, 2026132.60M127.57M▲ 0.30%
May 10, 2026132.60M127.18M▲ 1.14%
Apr 15, 2026131.17M125.75M▼ 0.02%
Apr 11, 2026131.17M125.78M▼ 0.01%
Apr 10, 2026131.17M125.80M▼ 0.25%
Apr 07, 2026131.17M126.11M▲ 0.23%
Apr 03, 2026131.17M125.83M▼ 0.38%
Mar 21, 2026131.17M126.31M▼ 0.02%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track GH Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment GH files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking GH — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,566+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for GH
GH FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.